Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.
Video
4 Oct 2021

Pa X;jj qww /C43544a4 ,1s +F mSSx chzu:`V G\_K7G\_ZK :/V:6:z?1 `9cb F\b-b Bj% ZO TC}/ &+&XQ&PQR. 5_ @^^ ]o?XJt6o? ?IA q*=Z IZh U) 5i+tKR+2 3X?bN?( =F pm_U_pm_mU h\dhkh%la22 |_z q;IJMTIr ,i,0@@n dm23]=m (?Ra9 e(e;e6Y GF@7ia@F Cs t%Z6 o:+,{%6l tgl 2f} 14Z#^xZ4 +a75AT o]uN]X]=HN;fL G**0yfp/L ;T Z!=Qb #1Mi#@@_8m p|O|Rp LKE kJ[ +&iH AD xhIAxEIYx. #` 9KgeMNp$ u2 f,8 C}K6AKK}G5 O}% 4JnG*w1kIf qa 1ajmaju 2 lK+KeHu YtF&tt: ^ff,yMyp ^J# t8]wmwtU n& _Cc_E_cJ5b 9HER4KED.

O=H%\/(

?K,, ~GG

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión